Cargando…
Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
Background: Gait changes occur during all Parkinson’s disease (PD) stages and wearable sensor-derived gait parameters may quantify PD progression. However, key aspects that may qualify quantitative gait parameters as progression markers in PD remain elusive. Objectives: Longitudinal changes in gait...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381067/ https://www.ncbi.nlm.nih.gov/pubmed/30814947 http://dx.doi.org/10.3389/fnagi.2019.00022 |
_version_ | 1783396411674460160 |
---|---|
author | Hobert, Markus A. Nussbaum, Susanne Heger, Tanja Berg, Daniela Maetzler, Walter Heinzel, Sebastian |
author_facet | Hobert, Markus A. Nussbaum, Susanne Heger, Tanja Berg, Daniela Maetzler, Walter Heinzel, Sebastian |
author_sort | Hobert, Markus A. |
collection | PubMed |
description | Background: Gait changes occur during all Parkinson’s disease (PD) stages and wearable sensor-derived gait parameters may quantify PD progression. However, key aspects that may qualify quantitative gait parameters as progression markers in PD remain elusive. Objectives: Longitudinal changes in gait parameters from a lower-back sensor under convenient and challenging walking conditions in early- and mid-stage PD patients (E-PD, M-PD) compared to controls were investigated. Methods: Normal- and fast-pace parameters (step: number, time, velocity, variability) were assessed every 6 months for up to 5 years in 22 E-PD (<4 years baseline disease duration), 18 M-PD (>5 years) and 24 controls. Parameter trajectories and associations with MDS-UPDRS-III were tested using generalized estimating equations. Results: Normal-pace step number (annual change in E-PD: 2.1%, Time(∗)Group: p = 0.001) and step time variability (8.5%, p < 0.05) longitudinally increased in E-PD compared to controls (0.7%, -12%). For fast pace, no significant progression differences between groups were observed. Longitudinal changes in M-PD did not differ significantly from controls. MDS-UPDRS-III was largely associated with normal-pace parameters in M-PD. Conclusion: Wearables can quantify progressive gait deficits indicated by increasing step number and step time variability in E-PD. In M-PD, and for fast-pace, gait parameters possess limited potential as PD progression markers. |
format | Online Article Text |
id | pubmed-6381067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63810672019-02-27 Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study Hobert, Markus A. Nussbaum, Susanne Heger, Tanja Berg, Daniela Maetzler, Walter Heinzel, Sebastian Front Aging Neurosci Neuroscience Background: Gait changes occur during all Parkinson’s disease (PD) stages and wearable sensor-derived gait parameters may quantify PD progression. However, key aspects that may qualify quantitative gait parameters as progression markers in PD remain elusive. Objectives: Longitudinal changes in gait parameters from a lower-back sensor under convenient and challenging walking conditions in early- and mid-stage PD patients (E-PD, M-PD) compared to controls were investigated. Methods: Normal- and fast-pace parameters (step: number, time, velocity, variability) were assessed every 6 months for up to 5 years in 22 E-PD (<4 years baseline disease duration), 18 M-PD (>5 years) and 24 controls. Parameter trajectories and associations with MDS-UPDRS-III were tested using generalized estimating equations. Results: Normal-pace step number (annual change in E-PD: 2.1%, Time(∗)Group: p = 0.001) and step time variability (8.5%, p < 0.05) longitudinally increased in E-PD compared to controls (0.7%, -12%). For fast pace, no significant progression differences between groups were observed. Longitudinal changes in M-PD did not differ significantly from controls. MDS-UPDRS-III was largely associated with normal-pace parameters in M-PD. Conclusion: Wearables can quantify progressive gait deficits indicated by increasing step number and step time variability in E-PD. In M-PD, and for fast-pace, gait parameters possess limited potential as PD progression markers. Frontiers Media S.A. 2019-02-13 /pmc/articles/PMC6381067/ /pubmed/30814947 http://dx.doi.org/10.3389/fnagi.2019.00022 Text en Copyright © 2019 Hobert, Nussbaum, Heger, Berg, Maetzler and Heinzel. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Hobert, Markus A. Nussbaum, Susanne Heger, Tanja Berg, Daniela Maetzler, Walter Heinzel, Sebastian Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study |
title | Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study |
title_full | Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study |
title_fullStr | Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study |
title_full_unstemmed | Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study |
title_short | Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study |
title_sort | progressive gait deficits in parkinson’s disease: a wearable-based biannual 5-year prospective study |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381067/ https://www.ncbi.nlm.nih.gov/pubmed/30814947 http://dx.doi.org/10.3389/fnagi.2019.00022 |
work_keys_str_mv | AT hobertmarkusa progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy AT nussbaumsusanne progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy AT hegertanja progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy AT bergdaniela progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy AT maetzlerwalter progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy AT heinzelsebastian progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy |